I-Fasoracetam (110958-19-5)

Kwangathi 7, 2021

ICofttek ingumkhiqizi weFasoracetam omuhle kakhulu eChina. Ifektri yethu inohlelo oluphelele lokuphathwa kokukhiqiza (i-ISO9001 & ISO14001), enekhono lokukhiqiza lenyanga elingu-150kg njalo ngenyanga.

 


Isimo: Ekukhiqizeni kweMisa
Iyunithi: 1kg / isikhwama, 25kg / Drum

I-Fasoracetam (110958-19-5) Siziqu

Igama: I-Fasoracetam
CAS: 110958-19-5
Ukuhlanzeka 98%
Ifomula Yamamolekhula: C10H16N2O2
Isisindo Yamamolekhula: I-196.250 g / mol
I-Melt Point: 57 ° C
Igama lamakhemikhali: (R) -1 - ((5-Oxo-2-pyrrolidinyl) carbonyl) piperidine
omqondofana: I-Fasoracetam; I-N- (5-Oxo-D-prolyl) i-piperidine; NS-105; I-NFC-1; I-LAM-105.
InChI Key: I-GOWRRBABHQUJMX-MRVPVSSYSA-N
Ukuphila okungaphelele: 1.5 amahora
Umswakama: I-Soluble ku-DMSO
Isimo Sokugcina: 0 - 4 C isikhathi esifushane (izinsuku kuya emavikini), noma -20 C isikhathi eside (izinyanga)
Isicelo: I-Fasoracetam yisidakamizwa esihlakaniphile noma i-nootropic okungeyomndeni odumile we-racetam wezidakamizwa.
ukubukeka: powder emhlophe

 

I-Fasoracetam (110958-19-5) I-NMR Spectrum

I-Fasoracetam (110958-19-5) - I-NMR Spectrum

Uma udinga i-COA, i-MSDS, i-HNMR yeqoqwana ngalinye lomkhiqizo nolunye ulwazi, sicela uxhumane nathi umphathi wezentengiso.

 

Yini iFasoracetam (110958-19-5)?

I-Fasoracetam (110958-19-5) eyaziwa nangokuthi yi-LAM-105, i-NFC-1, ne-NS-105, isidakamizwa esihlakaniphile noma i-nootropic esomndeni odumile wezidakamizwa ze-racetam. AmaNootropics akhula masinyane ekuthandeni ngenxa yekhono lawo lokuthuthukisa ukusebenza kwengqondo, ikakhulukazi imisebenzi ephezulu, ukugqugquzela, inkumbulo, noma ubuciko, kubantu abaphilile.

 

Izinzuzo zeFasoracetam (110958-19-5)

Ukugxila okuthuthukisiwe nokugxila

I-Fasoracetam inamandla okusebenzisa amazinga e-Choline ebuchosheni, isiza abasebenzisi ukuthi bazizwe begxile kahle futhi besezingeni, ngaphandle kwesidingo sokusebenzisa noma iziphi izikhuthazi ezingeziwe. Ngokungafani nezikhuthazi, le nootropic ikuvumela ukuthi uhlale ugxile futhi wenze yonke imisebenzi ephambi kwakho ngaphandle kokuzwa njengokuhambahamba ukukhulula amandla omzimba akhiwe. Ngamazwi alula, uzozola futhi uhlale ugxile emsebenzini wakho.

Ukunyuka kwamazinga we-choline nakho kungaholela ekuhlolweni okuthuthukisiwe. Lokhu kusho ukuthi abasebenzisi balesi sidakamizwa bangaba ngcono ekufundeni nasekusebenziseni ubuhlakani babo emazingeni aphezulu.

I-Fasoracetam powder isidakamizwa esihle kakhulu kunoma ngubani ofuna ukukhulisa imisebenzi yabo yokuqonda futhi afinyelele izithuthukisi abazidingayo, ngaphandle kokuzizwa enwebekile futhi engakwazi ukuhlala ezolile endaweni eyodwa.

Lezi zinzuzo zeFasoracetam nazo zihle kakhulu kubantu asebekhulile abaye bancipha ngokomqondo. Ngokusebenzisa i-fasoracetam, bayoba nekhono lokukhuluma kangcono, benze umqondo ongcono wokuthi kwenzekani ngabo futhi bazizwe bebancane ngemibono yokucabanga nokwahlulela.

 

Ukunciphisa Ukudangala nokukhathazeka

Enye inzuzo yeFasoracetam powder (110958-19-5) eyenza ukuthi ihluke kunoma yiluphi olunye uhlobo lwesidakamizwa sokukhathazeka ukuthi inikeza ukukhululeka okungewona umlutha nokubushelelezi ekukhathazeni ngaphandle kwe-'buzz 'ehambisanayo. Lo muthi ukwenza lokhu ngemiphumela yawo kuma-receptors wezinto ezimbili ezinkulu ezithonya imizwa ezinama-glutamate kanye ne-GABA.

Labo bantu abakhathazekile bavame ukuba nohlelo olusebenza kakhulu lwe-glutamate. Lokho okwenziwa yi-fasoracetam ukulinganisa lelo hlelo. Futhi, ivuselela ama-receptors e-GABA phezulu, ngaleyo ndlela inikeze umphumela wokuthoba ongahambisani nokuzela.

Imiphumela emihle ye-fasoracetam powder ayikhawulwanga kubantu. Isazi esithile se-fasoracetam nootropics sithe nezilwane zikhombisile nekhono lokuphatha izimo eziyinselele ngokuzola okukhulu ngemuva kokuthatha umuthi ngesikhathi sokuvivinywa.

 

I-Fasoracetam (110958-19-5) kusebenzisa?

Imoya ethuthukisiwe

Imiphumela yokuthuthuka kwesimo se-fasoracetam ayisiyo manjalo. Isebenza ngokuletha umuntu esimweni esingcono sengqondo kancane kancane ngokuhamba kwesikhathi. Njalo lapho umsebenzisi ethatha isengezo seFasoracetam, isidakamizwa sandisa ukusebenza kahle kwama-GABA receptors. Khumbula ukuthi kufakazelwe ngokwezokwelapha ukuthi amazinga ancishisiwe wokusebenza kuma-GABA receptors angadala isimo esiphansi.

Kucatshangelwa ukuthi izinto ezithuthukisa ukusebenza kwe-GABA receptor zingaba ngumlingo omusha wokuhlanganiswa kwe-antidepressant enhlobonhlobo yokusetshenziswa okungaba khona. Yingakho i-fasoracetam ingasebenza kakhulu kubasebenzisi abanokuphakama okuphakathi nokuzithemba.

Uma uhlangabezana nokukhathazeka komphakathi futhi uzizwa uphansi ngaso sonke isikhathi, i-fasoracetam ingakusiza uzizwe ungcono futhi ikufikise esimeni esingcono somqondo nogqozi. Okumangalisa nakakhulu ukuthi noma ngabe usuyekile ukukuthatha, ama-GABA receptors akho asazoqhubeka nokuthuthuka futhi ngeke uncike emithini ukuze uzizwe ungcono.

 

Inkumbulo ethuthukisiwe

Njengoba sishilo phambilini, i-Fasoracetam nootropic isebenza kumakhemikhali asevele atholakala ebuchosheni, afaka i-acetylcholine ne-choline, futhi ngale miphumela, inikela ngokuvikela okungcono ngaphakathi kobuchopho bethu. Ngokwengeziwe, njengamanye amaNootropics omndeni wakwaRacetam, futhi inezimfanelo ezithuthukisa ukugcinwa kwememori.

Lapho uthatha lo muthi, uzoba nokukhumbula okungcono okukhumbulekayo. Uzoba nekhono lokwenza izinkumbulo kahle. Lokhu kusho ukuthi uma ufunda okuthile ngenkathi ukwelashwa, uzoba nekhono lokugcina lolu lwazi ngempumelelo. Ngaphezu kwalokho, isiza isizukulwane esidala ekulweni nokuwohloka kwenkumbulo ngokuphumelelayo futhi sibe nememori engcono njengoba ikhula.

 

I-Fasoracetam (110958-19-5) isilinganiso

Imiphumela yalesi sidakamizwa kubantu abangakabhalwa ngokuphelele, ngakho-ke asikho isiqondisi esichazayo somthamo we-fasoracetam.

Ekuvivinyweni komtholampilo okubandakanya intsha ene-ADHD, i-fasoracetam yenziwa ngomlomo ngomthamo owodwa wokuqala we-50 mg kuya ku-800 mg, kwalandelwa imithamo eqhutshwa yizimpawu efinyelela ku-400 mg amahlandla amabili ngosuku amasonto amane. I-fasoracetam psychonaut eyodwa yathatha nje i-10mg ngosuku ngosuku oluncane futhi yakwazi ukufeza imiphumela eyifunayo.

Ocwaningweni lomtholampilo olubandakanya abesilisa abayi-14 baseJapan, kwanikezwa imithamo yansukuzonke yama-100 mg. Lo mthamo ubonakale usebenza kahle. Noma kunjalo, i-fasoracetam iyinhlanganisela enamandla kakhulu, futhi imithamo ephansi njengo-20 mg elawulwa kanye noma kabili ngosuku ibonakalise ukuthi isebenza kahle kwabanye abasebenzisi.

Ngawo wonke amaNootropics ngokufanayo ne-fasoracetam, kuwukuhlakanipha ukuqala ngomthamo osebenza kahle kakhulu futhi ukhuphuke kancane kancane njengoba kudingeka.

 

I-Fasoracetam powder ukudayiswa(Lapho Ungathenga khona i-Fasoracetam powder ngobuningi)

Inkampani yethu ithokozela ubudlelwane besikhathi eside namakhasimende ethu ngoba sigxile ekusebenzeni kwamakhasimende nokunikezela ngemikhiqizo emihle. Uma unentshisekelo ngomkhiqizo wethu, siyavumelana nezimo nge-oda eyenziwe ngokwezifiso ukuze ivumelane nesidingo sakho esithile nesikhathi sethu sokuhola esisheshayo kuma-oda siqinisekisa ukuthi uzowunambitha kakhulu umkhiqizo wethu ngesikhathi. Siphinde sigxile nezinsizakalo ezingezwe zenani. Sitholakala ngemibuzo yensiza nolwazi lokuxhasa ibhizinisi lakho.

Singumhlinzeki we-powder we-Fasoracetam okweminyaka eminingana, sihlinzeka ngemikhiqizo ngentengo yokuncintisana, futhi umkhiqizo wethu usezingeni eliphakeme kakhulu futhi uvivinywa ngokuqinile, nokuzimela ukuqinisekisa ukuthi kuphephile ukusetshenziswa emhlabeni wonke.

 

Okubhekwayo

[1] Ogasawara T, Itoh Y, Tamura M, et al. Ukubandakanywa kwezinhlelo ze-cholinergic ne-GABAergic ekuguqulweni kokuphazanyiswa kwememori yi-NS-105, isithuthukisi sokuqonda. I-Pharmacol Biochem Behav. 1999; 64 (1): 41-52. i-doi: 10.1016 / s0091-3057 (99) 00108-2

[2] U-Elia, J., Ungal, G., Kao, C. et al. I-Fasoracetam ebusheni obune-ADHD ne-glutamatergic gene network variants ephazamisa ukusayina kwe-mGluR neurotransmitter. UNat Commun 9, 4 (2018).

[3] I-Foran E, abathuthi bakaTrotti D. Glutamate kanye nendlela ye-excitotoxic eya ekushoneni kwemoto neuron ku-amyotrophic lateral sclerosis. Isibonakaliso se-Antioxid Redox. 2009; 11 (7): 1587-1602. i-doi: 10.1089 / ars.2009.2444